ASN007 is a selective ERK1/2 inhibitor with preferential activity against RAS-and RAF-mutant tumors-Reference-Cited by-同舟云学术

ASN007 is a selective ERK1/2 inhibitor with preferential activity against RAS-and RAF-mutant tumors

Published:2021-07 Issue:7 Volume:2 Page:100350
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Portelinha Ana,Thompson Scott,Smith Roger A.,Da Silva Ferreira Mariana,Asgari Zahra,Knezevic Andrea,Seshan Venkatraman,de Stanchina Elisa,Gupta Sandeep,Denis Louis,Younes Anas,Reddy Sanjeeva

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference42 articles.

1. Cancer genome landscapes;Vogelstein;Science,2013

2. Targeting RAS-ERK signalling in cancer: promises and challenges;Samatar;Nat. Rev. Drug Discov.,2014

3. Targeting the RAF-MEK-ERK pathway in cancer therapy;Montagut;Cancer Lett.,2009

4. The ERK Cascade: Distinct Functions within Various Subcellular Organelles;Wortzel;Genes Cancer,2011

5. Mouse tissues that undergo neoplastic progression after K-Ras activation are distinguished by nuclear translocation of phospho-Erk1/2 and robust tumor suppressor responses;Parikh;Mol. Cancer Res.,2012

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibiting the Extracellular Signal-regulated Kinase 1/2 (ERK1/2) Cascade in Cancer and the Heart: for Better or Worse, in Sickness and Health?;International Journal of Drug Discovery and Pharmacology;2024-05-23

2. Targeting RAF dimers in RAS mutant tumors: From biology to clinic;Acta Pharmaceutica Sinica B;2024-05

3. Structure-Guided Discovery and Preclinical Assessment of Novel (Thiophen-3-yl)aminopyrimidine Derivatives as Potent ERK1/2 Inhibitors;Journal of Medicinal Chemistry;2024-04-13

4. Genetic profile of thymic epithelial tumors in the Japanese population: an exploratory study examining potential therapeutic targets;Translational Lung Cancer Research;2023-04

5. Novel thiazolidines of potential anti-proliferation properties against esophageal squamous cell carcinoma via ERK pathway;European Journal of Medicinal Chemistry;2023-01